CUBIST PHARMACEUTICALS INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2013 12 months to Dec 31, 2013	FY2012 12 months to Dec 31, 2012	FY2011 12 months to Dec 31, 2011	FY2010 12 months to Dec 31, 2010
Net income
Cash flows from operating activities:
Net (loss) income
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Loss on debt repurchase, including debt issuance costs write-off
Loss on extinguishment of convertible debt, including write-off of debt issuance costs
Depreciation and amortization
Amortization and accretion of investments
Amortization of debt discount and debt issuance costs, excluding write-off of debt issuance costs
Premium paid for convertible subordinated debt repurchase
Deferred income taxes
Stock-based compensation
Contingent consideration
Payment of contingent consideration
Impairment of in-process research and development
Impairment charges
Other non-cash
Changes in assets and liabilities, net of effects from acquisitions:
Accounts receivable
Inventory
Prepaid expenses and other current assets
Other assets
Accounts payable and accrued liabilities
Deferred revenue and other liabilities
Total adjustments
Gain on auction rate securities
Foreign exchange (gain) loss
Contingent consideration
Charge for company 401(k) common stock match
Other non-cash

Net cash provided by operating activities
Cash flows from investing activities:
Acquisition of business, net of acquired cash
Purchases of property and equipment
Purchases of investments
Proceeds from maturities of investments
Payment for purchase option
Net cash used in investing activities
Cash flows from financing activities:
Payment of contingent consideration
Issuance of common stock
Excess tax benefit on stock-based awards
Extinguishment of convertible debt
Proceeds from issuance of convertible debt
Payment of debt issuance costs
Proceeds from issuance of warrants
Purchase of convertible bond hedge
Net cash provided by (used in) financing activities
Net increase (decrease) in cash and cash equivalents
Effect of changes in foreign exchange rates on cash balances

Net decrease in cash and cash equivalents
Effect of changes in foreign exchange rates on cash balances
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Cash paid during the year for:
Interest, net of amounts capitalized
Income taxes
Supplemental disclosures of non-cash flow information:
Non-cash investing and financing activities:
Purchases of property and equipment

Comments